NSE · WINDLAS
Windlas Biotech Limited (WINDLAS) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,221
of 5,047 stocks
▼ 231W▲ 281M
Peak #1,159 · 21 Sep 2026
Operating in Healthcare, Windlas Biotech Limited remains firmly promoter-controlled, with promoters holding 63%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
2,016.55 Cr
P/E Ratio
30.92
P/B Ratio
3.55
ROE
11.44%
ROCE
15.65%
Dividend Yield
0.64%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 263.91 Cr | 248.10 Cr | 238.50 Cr | 233.10 Cr |
| Net Profit | 18.05 Cr | 17.65 Cr | 15.99 Cr | 15.00 Cr |
| EPS | 8.75 | 8.46 | 7.58 | 7.12 |
| Operating Profit | 25.63 Cr | 24.59 Cr | 21.64 Cr | 21.25 Cr |
Shareholding pattern
Promoter
63.31%
Public
36.69%
PUBLIC BREAKDOWN
FII
2.04%
DII
9.84%
MF (within DII)
5.76%
Individuals
21.76%
Mutual fund holdings
₹68.05
Cr total
5
Schemes
4
Fund Houses
₹68.05 Cr
Total Exposure
ICICI Prudential Mutual Fund₹31.19 Cr (45.8%)
Bandhan Mutual Fund₹18.66 Cr (27.4%)
UTI Mutual Fund₹18.18 Cr (26.7%)
Motilal Oswal Mutual Fund₹0.02 Cr (0.0%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 16 Jul 2026 | Dividend | Dividend - Rs 6.30 Per Share |
| 24 Apr 2026 | Buyback | Buy Back |
| 21 Jul 2025 | Dividend | Dividend - Rs 5.80 Per Share |
| 17 Sep 2024 | Other | Annual General Meeting |
| 17 Sep 2024 | Dividend | Dividend - Rs 5.50 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.